Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

G-protein Coupled Receptors

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Bone Formation by Endochondral Ossification

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Two decades into the crosstalk between bone and energy metabolism.

Nature reviews. Endocrinology·2025

Same author

Rapid and relaying deleterious effects of a gastrointestinal pathogen, <i>Citrobacter</i> <i>rodentium</i>, on bone, an extra-intestinal organ.

iScience·2025

Same author

Taurine/chenodeoxycholic acid ratio as a potential serum biomarker for low vitamin B<sub>12</sub> levels in humans.

The British journal of nutrition·2024

Same author

Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring.

EMBO reports·2024

Same author

Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring.

bioRxiv : the preprint server for biology·2023

Same author

Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.

Journal of Alzheimer's disease : JAD·2023

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Lrp5 and bone formation : A serotonin-dependent pathway.

Vijay K Yadav¹, Patricia Ducy

¹Department of Pathology, Columbia University, College of Physicians and Surgeons, New York, New York, USA.

Annals of the New York Academy of Sciences

|April 16, 2010

Summary

This summary is machine-generated.

The Lrp5 gene regulates bone formation by controlling gut serotonin production, not directly acting on bone cells. Lowering serotonin levels can rescue bone density, offering new therapeutic targets for bone disorders.

More Related Videos

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

Related Experiment Videos

Last Updated: Jun 13, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

Area of Science:

Endocrinology
Bone Biology
Genetics

Background:

The Lrp5 gene is implicated in osteoporosis pseudoglioma (OPPG) and high bone-mass (HBM) syndromes, regulating bone formation.
Beta-catenin, a Wnt signaling component, is known to influence bone resorption, suggesting Lrp5 might act independently of Wnt signaling.

Purpose of the Study:

To investigate the mechanism by which Lrp5 regulates bone formation.
To explore a potential Wnt-independent role for Lrp5 in bone metabolism.

Main Methods:

Utilized microarray analysis and conditional gene deletion in mice.
Measured circulating serotonin levels and analyzed gene expression in the duodenum.

Main Results:

Lrp5 enhances bone formation by inhibiting duodenal tryptophan hydroxylase 1, the enzyme for serotonin synthesis.
Mice lacking Lrp5 (Lrp5(-/-)) and OPPG patients exhibit high serotonin levels, while HBM patients show low levels.
Restoring normal serotonin levels in Lrp5(-/-) mice ameliorated their bone phenotype.
Serotonin inhibits osteoblast proliferation via the Htr1b receptor and cAMP responsive element binding (CREB).

Conclusions:

Lrp5 regulates bone formation through a Wnt-independent pathway by acting on gut cells to control serotonin production.
Serotonin emerges as a novel hormone and a key regulator in a newly identified endocrine axis governing bone mass.
These findings hold potential for developing new therapies for bone mass disorders.